The E3 ligase Itch in immune regulation and beyond

By  

IMMUNOLOGICAL REVIEWS (ELECTRONIC), Vol. 266, Iss. 1, 2015-07 ,pp. : 6-26

John Wiley & Sons Inc

Access to resources Recommend Favorite

Disruption of KEAP1/CUL3/RBX1 E3‐ubiquitin ligase complex components by multiple genetic mechanisms: Association with poor prognosis in head and neck cancer

By  

HEAD & NECK: JOURNAL FOR THE SCIENCES & SPECIALTIES OF THE HEAD AND NECK, Vol. 37, Iss. 5, 2015-05 ,pp. : 727-734

John Wiley & Sons Inc

Access to resources Recommend Favorite

RING-finger type E3 ubiquitin ligase inhibitors as novel candidates for the treatment of rheumatoid arthritis

By Yagishita Naoko   Aratani Satoko   Leach Craig   Amano Tetsuya   Yamano Yoshihisa   Nakatani Ko   Nishioka Kusuki   Nakajima Toshihiro  

International Journal of Molecular Medicine, Vol. 30, Iss. 6, 2012-12 ,pp. : 1281-1286

Spandidos Publications

Access to resources Recommend Favorite

Resistance to UV‐induced apoptosis by β‐HPV5 E6 involves targeting of activated BAK for proteolysis by recruitment of the HERC1 ubiquitin ligase

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 136, Iss. 12, 2015-06 ,pp. : 2831-2843

John Wiley & Sons Inc

Access to resources Recommend Favorite

Polyglucosan body myopathy caused by defective ubiquitin ligase RBCK1

By  

ANNALS OF NEUROLOGY, Vol. 74, Iss. 6, 2013-12 ,pp. : 914-919

John Wiley & Sons Inc

Access to resources Recommend Favorite